These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11726505)

  • 1. Glycosylation influences cross-species formation of protease-resistant prion protein.
    Priola SA; Lawson VA
    EMBO J; 2001 Dec; 20(23):6692-9. PubMed ID: 11726505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.
    Horiuchi M; Priola SA; Chabry J; Caughey B
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5836-41. PubMed ID: 10811921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
    Horiuchi M; Caughey B
    EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein.
    Wong C; Xiong LW; Horiuchi M; Raymond L; Wehrly K; Chesebro B; Caughey B
    EMBO J; 2001 Feb; 20(3):377-86. PubMed ID: 11157745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion protein and species barriers in the transmissible spongiform encephalopathies.
    Priola SA
    Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
    Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of scrapie strain glycoform variation.
    Vorberg I; Priola SA
    J Biol Chem; 2002 Sep; 277(39):36775-81. PubMed ID: 12138171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.
    Lawson VA; Priola SA; Wehrly K; Chesebro B
    J Biol Chem; 2001 Sep; 276(38):35265-71. PubMed ID: 11466311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.
    Priola SA; Chabry J; Chan K
    J Virol; 2001 May; 75(10):4673-80. PubMed ID: 11312338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.
    Priola SA; Chesebro B
    J Virol; 1995 Dec; 69(12):7754-8. PubMed ID: 7494285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of protease-resistant prion protein in cell-free systems.
    Caughey B
    Curr Issues Mol Biol; 2000 Jul; 2(3):95-101. PubMed ID: 11471561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
    Bessen RA; Raymond GJ; Caughey B
    J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
    Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
    Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.
    Vorberg I; Raines A; Priola SA
    J Biol Chem; 2004 Jul; 279(28):29218-25. PubMed ID: 15133048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform.
    Baron GS; Caughey B
    J Biol Chem; 2003 Apr; 278(17):14883-92. PubMed ID: 12594216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glycosylation status of PrPC is a key factor in determining transmissible spongiform encephalopathy transmission between species.
    Wiseman FK; Cancellotti E; Piccardo P; Iremonger K; Boyle A; Brown D; Ironside JW; Manson JC; Diack AB
    J Virol; 2015 May; 89(9):4738-47. PubMed ID: 25673720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chaperone-supervised conversion of prion protein to its protease-resistant form.
    DebBurman SK; Raymond GJ; Caughey B; Lindquist S
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13938-43. PubMed ID: 9391131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting interactions between prion protein isoforms.
    Caughey B; Baron GS
    Biochem Soc Trans; 2002 Aug; 30(4):565-9. PubMed ID: 12196138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.